EMO Biomedicine was founded in 2004. EMO is the first contract research organization (CRO) that focuses on cell-based assay and therapeutic cell-based product in Taiwan. EMO is one of the qualified CRO for pharmaceuticals declared by Ministry of Economic Affairs, Taiwan.
EMO's Testing Lab is in compliance with ISO/IEC 17025 and accredited by Taiwan Accreditation Foundation (TAF) and TFDA. The accredited testing scope includes cell-based products, biologics, cell culture supernatant, and whole blood.
EMO's manufacturing facility and quality management systems for therapeutic cell-based product has been inspected by TFDA for the compliance of Good Tissue Practice (GTP) guidance. In December 2019, EMO's Cell Processing Unit (CPU) received the certificate of manufacturing MSC-based product from TFDA. EMO is able to offer a complete service, including manufacturing and comprehensive testing, for local and oversea clients.
Address：8F., No.29-1, Sec. 2, Zhongzheng E. Rd., Danshui Dist., New Taipei City 251, Taiwan